News
Mushrooms sold across two states have been recalled over fears they could be harboring listeria, a bug that "can cause ...
The U.S. Food and Drug Administration ( FDA) has placed an immediate clinical hold on Sarepta Therapeutics' investigational ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
The U.S. Food and Drug Administration named ex-biotech exec George Tidmarsh as its chief drug regulator. FDA Commissioner ...
The FDA on Tuesday rejected a skin therapy from Replimune Group, suggesting a hardened stance on drug approvals under new agency officials ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
Pennsylvania-based A.P. Deauville, LLC is recalling several types of its Power Stick deodorant, due to a process issue.
The Food and Drug Administration on Monday named a longtime pharmaceutical executive to run the agency’s drug program, the ...
Food and Drug Administration commissioner Marty Makary has chosen former biotech executive George Tidmarsh as the agency’s ...
The FDA granted an orphan drug designation to novel hedgehog pathway inhibitor taladegib, also known as ENV-101, for treating ...
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine ...
Tidmarsh, who has founded and served as CEO of several biotech companies, will lead a crucial FDA division that reviews the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results